propafenone hydrochloride
Generic: propafenone hydrochloride
Labeler: glenmark pharmaceuticals inc., usaDrug Facts
Product Profile
Brand Name
propafenone hydrochloride
Generic Name
propafenone hydrochloride
Labeler
glenmark pharmaceuticals inc., usa
Dosage Form
CAPSULE, EXTENDED RELEASE
Routes
Active Ingredients
propafenone hydrochloride 425 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
68462-410
Product ID
68462-410_9b3e09a2-c396-425e-a1dc-e37cd44b612d
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA205268
Listing Expiration
2027-12-31
Marketing Start
2017-09-08
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
68462410
Hyphenated Format
68462-410
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
propafenone hydrochloride (source: ndc)
Generic Name
propafenone hydrochloride (source: ndc)
Application Number
ANDA205268 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 425 mg/1
Packaging
- 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-410-60)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "9b3e09a2-c396-425e-a1dc-e37cd44b612d", "openfda": {"upc": ["0368462409602", "0368462410608", "0368462408605"], "unii": ["33XCH0HOCD"], "rxcui": ["861156", "861164", "861171"], "spl_set_id": ["d818af31-2535-4595-82fe-fd7abf66fd6c"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-410-60)", "package_ndc": "68462-410-60", "marketing_start_date": "20170908"}], "brand_name": "propafenone hydrochloride", "product_id": "68462-410_9b3e09a2-c396-425e-a1dc-e37cd44b612d", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Antiarrhythmic [EPC]"], "product_ndc": "68462-410", "generic_name": "propafenone hydrochloride", "labeler_name": "Glenmark Pharmaceuticals Inc., USA", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "propafenone hydrochloride", "active_ingredients": [{"name": "PROPAFENONE HYDROCHLORIDE", "strength": "425 mg/1"}], "application_number": "ANDA205268", "marketing_category": "ANDA", "marketing_start_date": "20170908", "listing_expiration_date": "20271231"}